Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It's marketed under brand names like Wegovy, designed specifically for weight management, and Ozempic, originally for type 2 diabetes
Report suspected side effects or device problems to the MHRA via the Yellow Card scheme
J Endocrinol 196:5765
Clinical trials have demonstrated that patients taking semaglutide, marketed as Wegovy for weight loss, lose an average of about 15% of their body weight over approximately 68 weeks when combined with diet and exercise
Studies have shown that people with poorly controlled Type 2 diabetes may be at a very high risk (45-90%) for the development of certain types of dementia
US$ 27.64
US$ 20.61
US$ 25.04
US$ 21.54
US$ 23.43
US$ 21.04
US$ 20.94
